These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32192818)

  • 21. [Migraine Mechanisms: In Relation to the Premonitory Phase and CGRP/CGRP Receptor Antagonists].
    Awaki E; Takeshima T
    Brain Nerve; 2021 Apr; 73(4):303-313. PubMed ID: 33824218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Trigeminovascular Pathway: Role of CGRP and CGRP Receptors in Migraine.
    Edvinsson L
    Headache; 2017 May; 57 Suppl 2():47-55. PubMed ID: 28485848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CGRP and PACAP-38 play an important role in diagnosing pediatric migraine.
    Liu J; Wang G; Dan Y; Liu X
    J Headache Pain; 2022 Jun; 23(1):68. PubMed ID: 35698032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of genetics on migraine induction triggered by CGRP and PACAP38.
    Guo S
    Dan Med J; 2017 Mar; 64(3):. PubMed ID: 28260603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calcitonin gene-related peptide: a key player neuropeptide in migraine].
    Ramos-Romero ML; Sobrino-Mejia FE
    Rev Neurol; 2016 Nov; 63(10):460-468. PubMed ID: 27819404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Migraine and neuropeptides.
    Tajti J; Szok D; Majláth Z; Tuka B; Csáti A; Vécsei L
    Neuropeptides; 2015 Aug; 52():19-30. PubMed ID: 26094101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology of migraine--from molecular to personalized medicine.
    Kojić Z; Stojanović D
    Med Pregl; 2013; 66(1-2):53-7. PubMed ID: 23534301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of calcitonin gene-related peptide function: a promising strategy for treating migraine.
    Durham PL
    Headache; 2008 Sep; 48(8):1269-75. PubMed ID: 18808507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningeal afferent signaling and the pathophysiology of migraine.
    Burgos-Vega C; Moy J; Dussor G
    Prog Mol Biol Transl Sci; 2015; 131():537-64. PubMed ID: 25744685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropeptide effects in the trigeminal system: pathophysiology and clinical relevance in migraine.
    Messlinger K; Fischer MJ; Lennerz JK
    Keio J Med; 2011; 60(3):82-9. PubMed ID: 21979827
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What have we learnt from triggering migraine?
    Schytz HW; Schoonman GG; Ashina M
    Curr Opin Neurol; 2010 Jun; 23(3):259-65. PubMed ID: 20173638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migraine, Neurogenic Inflammation, Drug Development - Pharmacochemical Aspects.
    Lukacs M; Tajti J; Fulop F; Toldi J; Edvinsson L; Vecsei L
    Curr Med Chem; 2017; 24(33):3649-3665. PubMed ID: 28707585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lasmiditan mechanism of action - review of a selective 5-HT
    Clemow DB; Johnson KW; Hochstetler HM; Ossipov MH; Hake AM; Blumenfeld AM
    J Headache Pain; 2020 Jun; 21(1):71. PubMed ID: 32522164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neurovascular mechanisms of migraine and cluster headache.
    Hoffmann J; Baca SM; Akerman S
    J Cereb Blood Flow Metab; 2019 Apr; 39(4):573-594. PubMed ID: 28948863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of migraine--new insights.
    Hargreaves RJ; Shepheard SL
    Can J Neurol Sci; 1999 Nov; 26 Suppl 3():S12-9. PubMed ID: 10563228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of pituitary adenylate cyclase-activating polypeptide in nociception and migraine.
    Tajti J; Tuka B; Botz B; Helyes Z; Vecsei L
    CNS Neurol Disord Drug Targets; 2015; 14(4):540-53. PubMed ID: 25921738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cortical spreading depression and calcitonin gene-related peptide: a brief review of current progress.
    Wang M
    Neuropeptides; 2013 Dec; 47(6):463-6. PubMed ID: 24220568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcitonin gene-related peptide levels in tear fluid are elevated in migraine patients compared to healthy controls.
    Kamm K; Straube A; Ruscheweyh R
    Cephalalgia; 2019 Oct; 39(12):1535-1543. PubMed ID: 31603037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cortical spreading depression does not result in the release of calcitonin gene-related peptide into the external jugular vein of the cat: relevance to human migraine.
    Piper RD; Edvinsson L; Ekman R; Lambert GA
    Cephalalgia; 1993 Jun; 13(3):180-3; discussion 149. PubMed ID: 8395344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.